Chronos Archive seal
The Human Record

Voltaire

Case HR-EN002-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
21 November 1694 – 30 May 1778
Synthetic DOB
1694-11-21
Index visit
1778-04-06 at age 83
Synthetic MRN
HR-EN002-SYN-TD

Teaching objective: Evaluate visible blood in the urine with difficult urination in a frail man of 83: urinalysis with microscopy and culture, kidney function, bladder scan, and catheter drainage of chronic retention with a medication review that stops an anticholinergic sleep aid; PSA by shared decision; CT urography with chest CT and cystoscopy (AUA/SUFU); resection and staging of a muscle-invasive squamous cell carcinoma of the bladder; a geriatric assessment and shared decision on cystectomy, trimodality therapy, and palliative hypofractionated radiotherapy matched to his goals; a febrile catheter-associated infection; and safe, low-dose opioid prescribing with naloxone in a patient with a documented opium overdose (CDC 1774, AGS Beers 1775).

Historical timeline

DateEventClaims
21 November 1694Born in Paris (the date on his birth certificate).CLM-0001
1717Nearly a year in the Bastille.CLM-0002
1718Adopts the name Voltaire.CLM-0001
4 November 1723Falls ill with smallpox at Maisons; out of danger by 15 November.CLM-0003
5 May 1726Conducted to Calais, whence he leaves for London.CLM-0002
1769Writes that he has always had a feeble constitution.CLM-0004
10 February 1778Returns to Paris after 28 years.CLM-0005
25 February 1778Blood spurts from his mouth and nose after a fit of coughing; bleeding continues for several days.CLM-0006
30 March 1778Acclaimed at the Académie and crowned at a performance of Irène.CLM-0005
Mid-May 1778Takes a large dose of an opium preparation; strangury and catheterization in his last weeks.CLM-0007, CLM-0008, CLM-0009
18 May 1778Stricken with uremia, by Britannica's account.CLM-0009
30 May 1778Dies in Paris, aged 83.CLM-0010
31 May 1778Report of the opening of the body: diseased, thickened bladder; very large, hard prostate.CLM-0011
2025Retrospective study proposes perforated squamous cell cancer of the bladder.CLM-0012

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Voltaire, the pen name of François-Marie Arouet, was born in Paris; his birth certificate gives 21 November 1694, although he stated on several occasions that he was in fact born on 20 February. He was born into a wealthy bourgeois family; his putative father, François Arouet, became a receiver in the Cour des Comptes (the audit office), and he lost his mother when he was seven. He adopted the name Voltaire in 1718.
The cause of his mother's death is not recorded in the cited sources.
confirmed Pomeau RH. Voltaire. Encyclopaedia Britannica supports
About Voltaire supports
D He was imprisoned in the Bastille for nearly a year in 1717 after mocking the regent, and in May 1726, after a quarrel with the chevalier de Rohan, was beaten, taken to the Bastille, and conducted to Calais, whence he left for London. confirmed Pomeau RH. Voltaire. Encyclopaedia Britannica supports
D In a letter to the baron de Breteuil dated December 1723, he gave an account of the smallpox from which he was recovering: he fell ill on 4 November at Maisons; the disease declared itself after two days of fever with a slight eruption; the physician Gervasi had him take an emetic eight times and drink two hundred pints of lemonade, he had himself bled a second time on his own authority, and by the 15th he was out of danger.
His own contemporary account of an illness he survived.
confirmed Voltaire. Letter to the baron de Breteuil, December 1723 (Correspondance, Garnier edition, letter 101) supports
Russell A. Voltaire's thoughts on death. OUPblog, 29 May 2018 context
D His biographer Jean Orieux, as summarized in a 1970 review in the Revue d'histoire de la pharmacie, describes a lifelong preoccupation with illness and remedies: he suffered from colic, took as many as eight purges and twelve enemas in a month, was persuaded he would die before forty, and really did suffer from his kidneys and bladder. In a letter of 1769 he wrote that being very ill was the common lot of old age, especially for one who had always had a feeble constitution.
A biographer's summary and his own words; they record digestive and urinary complaints and frequent self-medication, not a diagnosis.
confirmed Julien P. Les maladies et la mort de Voltaire: Jean Orieux, Voltaire ou la Royauté de l'esprit [review]. Revue d'histoire de la pharmacie 1970;58(204):60-61 supports
Russell A. Voltaire's thoughts on death. OUPblog, 29 May 2018 supports
D He returned to Paris on 10 February 1778, for the first time in 28 years, to direct rehearsals of his tragedy Irène; more than 300 people called on him the day after his arrival. On 30 March he went to the Académie amid acclamations and was crowned in his box at a performance of Irène. His deteriorating health did not permit his return to Ferney. confirmed Pomeau RH. Voltaire: Achievements at Ferney. Encyclopaedia Britannica supports
About Voltaire supports
D His secretary Jean-Louis Wagnière recorded that on 25 February 1778, at a quarter past noon, while dictating from his bed, he coughed three times and said that he was spitting blood, and that blood then spurted from his mouth and nose. A declaration in his hand of 2 March 1778 states that he had been attacked for four days by a vomiting of blood, and the blood loss continued for several days.
Contemporary accounts of hemorrhage from the mouth and nose; the source of bleeding was not established. The surgeon who opened the body reported that the vessel whose rupture caused this first illness had healed.
confirmed Lachèvre F. Voltaire mourant: enquête faite en 1778 sur les circonstances de sa dernière maladie. Paris: Champion; 1908 supports
R An anonymous and hostile manuscript account of 1778, published by Frédéric Lachèvre in 1908, claims that in May 1778, before a meeting at the Académie, he secretly took as many as eighteen cups of coffee.
A single anecdote in a hostile source; the roster's figure of 40 to 50 cups a day was not found in any source read.
possible Lachèvre F. Voltaire mourant: enquête faite en 1778 sur les circonstances de sa dernière maladie. Paris: Champion; 1908 supports
D In mid-May 1778, according to Wagnière's account, he was persuaded to take a liquor brought by an apothecary and then, in great agitation, asked the maréchal de Richelieu to send him some of his prepared opium; one witness said he saw him finish the bottle. The anonymous manuscript says he took the whole vial at once instead of dividing it into three or four doses. Orieux's account has him refuse the apothecary's remedy and accept the opium preparation brought by Richelieu, after which he felt a trail of fire from throat to bowels and became frenzied.
Several contemporary and later accounts agree that he took a large dose of an opium preparation in mid-May and differ in the details; the amount is unknown.
confirmed Lachèvre F. Voltaire mourant: enquête faite en 1778 sur les circonstances de sa dernière maladie. Paris: Champion; 1908 supports
Julien P. Les maladies et la mort de Voltaire: Jean Orieux, Voltaire ou la Royauté de l'esprit [review]. Revue d'histoire de la pharmacie 1970;58(204):60-61 supports
D In his last weeks he suffered from strangury and needed frequent catheterization by the surgeon Try; the anonymous manuscript describes a bladder holding as much pus as urine, which could be emptied only with a catheter, and a burning heat over the lower abdomen. Britannica records that on 18 May he was stricken with uremia and that he suffered much pain on his deathbed.
Contemporary descriptions of painful urination, retention needing a catheter, and infected urine; 'uremia' is a later encyclopedia's term.
confirmed Lachèvre F. Voltaire mourant: enquête faite en 1778 sur les circonstances de sa dernière maladie. Paris: Champion; 1908 supports
Pomeau RH. Voltaire: Achievements at Ferney. Encyclopaedia Britannica supports
D He died in Paris on 30 May 1778, aged 83, peacefully it seems, according to Britannica; his body was taken to the Abbey of Scellières and given Christian burial there, and his remains were later transferred to the Panthéon.
Record the death as a fact without graphic detail.
confirmed Pomeau RH. Voltaire: Achievements at Ferney. Encyclopaedia Britannica supports
Pomeau RH. Voltaire. Encyclopaedia Britannica supports
D The report of the opening and embalming of his body, dated 31 May 1778 and signed by the surgeon Try, found the brain and the organs of the chest healthy; the bladder was diseased, more than an inch thick at its upper and posterior part, with a lard-like substance and suppurating tubercles whose pus had leaked into the abdomen over the nearby intestines; the right kidney bore gangrenous marks; and the prostate was very large and entirely scirrhous. The anonymous manuscript adds that the bladder held about a pint of pus and was perforated at its base.
An eighteenth-century gross description without microscopy; 'scirrhous' meant hard.
confirmed Lachèvre F. Voltaire mourant: enquête faite en 1778 sur les circonstances de sa dernière maladie. Paris: Champion; 1908 supports
R Retrospective readings of his final illness differ. A 2025 paleoproteomic study of blood residues by Charlier and colleagues concluded that he died of a perforated squamous cell cancer of the bladder with peritoneal extension; Britannica describes uremia; the autopsy's very large, hard prostate leaves prostate disease, benign or malignant, as a further possibility.
Retrospective interpretations; the 2025 study is known here only from its published title and bibliographic record. The record does not assert any of them as his historical diagnosis.
disputed Charlier P, Neuzillet Y, Le Gendre R, Armengaud J. Paleoproteomic study of blood residues shows that Voltaire (1778) died of perforated bladder squamous cell cancer with peritoneal extension. BJU Int 2025;136(6):1002-1003. PMID 40977402 supports
Pomeau RH. Voltaire: Achievements at Ferney. Encyclopaedia Britannica supports
Lachèvre F. Voltaire mourant: enquête faite en 1778 sur les circonstances de sa dernière maladie. Paris: Champion; 1908 context

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Visible blood in the urine for three weeks with clots, and a weak stream, straining, and frequent small voids, in a man of 83; under evaluation resolved confirmed active CLM-0004, CLM-0009
S Chronic urinary retention with overflow (post-void residual 460 mL at intake), worsened by a nightly anticholinergic sleep aid; drained by an indwelling catheter active confirmed active CLM-0009
S Acute kidney injury from bladder outlet obstruction (creatinine 1.68 mg/dL, from 1.1 mg/dL a year earlier) resolved confirmed active CLM-0009
S Benign prostatic hyperplasia with lower urinary tract symptoms: prostate about 78 mL on CT, enlarged, firm, and smooth on examination, PSA 6.4 ng/mL with a PSA density of 0.08; no prostate biopsy, by shared decision active confirmed active CLM-0011
S Squamous cell carcinoma of the bladder, keratinizing, posterior wall extending to the dome, muscle-invasive with extravesical extension (clinical stage cT3b N0 M0, stage IIIA), pure squamous histology without a urothelial component; treated with palliative-intent hypofractionated radiotherapy by shared decision active confirmed both_with_link CLM-0009, CLM-0011, CLM-0012
S Chronic constipation, lifelong by his account, with long use of laxatives and self-given enemas active confirmed active CLM-0004
S Febrile catheter-associated urinary tract infection with Escherichia coli, five days after bladder tumor resection; treated with cefpodoxime and a catheter change; resolved resolved confirmed active CLM-0009

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1778-04-06 Erythrocytes [#/area] in Urine sediment by Microscopy high power field 75 /[HPF] (high)
Reference 0 to 2 per high-power field; 3 or more is microhematuria (AUA/SUFU)
http://loinc.org · 13945-1
S 1778-04-06 Leukocytes [#/area] in Urine sediment by Microscopy high power field 8 /[HPF] (high)
Reference <=5 /[HPF]
http://loinc.org · 5821-4
S 1778-04-06 International Prostate Symptom Score [IPSS] 22 http://loinc.org · 80976-4
S 1778-04-06 US Urinary bladder Volume post void 460 mL (high)
Reference Below 100 mL; 300 mL or more suggests chronic retention
http://loinc.org · 98856-8
S 1778-04-06 Hemoglobin [Mass/volume] in Blood 11.6 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1778-04-06 Leukocytes [#/volume] in Blood by Automated count 7.8 10*3/uL
Reference 3.4-9.6 10*3/uL
http://loinc.org · 6690-2
S 1778-04-06 Platelets [#/volume] in Blood by Automated count 268 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1778-04-06 Sodium [Moles/volume] in Serum or Plasma 138 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1778-04-06 Potassium [Moles/volume] in Serum or Plasma 5 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1778-04-06 Carbon dioxide, total [Moles/volume] in Serum or Plasma 21 mmol/L (low)
Reference 22-29 mmol/L
http://loinc.org · 2028-9
S 1778-04-06 Urea nitrogen [Mass/volume] in Serum or Plasma 34 mg/dL (high)
Reference 8-24 mg/dL
http://loinc.org · 3094-0
S 1778-04-06 Creatinine [Mass/volume] in Serum or Plasma 1.68 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1778-04-06 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1773)/1.73 sq M 40 mL/min/1.73 m² (low)
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1778-04-06 Glucose [Mass/volume] in Serum or Plasma 96 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1778-04-06 Prostate specific Ag [Mass/volume] in Serum or Plasma 6.4 ng/mL (high)
Reference <=4 ng/mL
http://loinc.org · 2857-1
S 1778-04-13 Hemoglobin [Mass/volume] in Blood 11.2 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1778-04-13 Potassium [Moles/volume] in Serum or Plasma 4.6 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1778-04-13 Urea nitrogen [Mass/volume] in Serum or Plasma 22 mg/dL
Reference 8-24 mg/dL
http://loinc.org · 3094-0
S 1778-04-13 Creatinine [Mass/volume] in Serum or Plasma 1.24 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1778-04-13 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1773)/1.73 sq M 58 mL/min/1.73 m² (low)
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1778-04-20 Leukocytes [#/area] in Urine sediment by Microscopy high power field 60 /[HPF] (high)
Reference <=5 /[HPF]
http://loinc.org · 5821-4
S 1778-04-20 Leukocytes [#/volume] in Blood by Automated count 12.6 10*3/uL (high)
Reference 3.4-9.6 10*3/uL
http://loinc.org · 6690-2
S 1778-04-20 Creatinine [Mass/volume] in Serum or Plasma 1.34 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1778-04-20 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1773)/1.73 sq M 53 mL/min/1.73 m² (low)
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1778-04-20 Potassium [Moles/volume] in Serum or Plasma 4.7 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1778-04-22 Hemoglobin [Mass/volume] in Blood 10.9 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1778-04-22 Leukocytes [#/volume] in Blood by Automated count 8.2 10*3/uL
Reference 3.4-9.6 10*3/uL
http://loinc.org · 6690-2
S 1778-04-22 Platelets [#/volume] in Blood by Automated count 254 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1778-04-22 Potassium [Moles/volume] in Serum or Plasma 4.5 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1778-04-22 Creatinine [Mass/volume] in Serum or Plasma 1.22 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1778-04-22 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1773)/1.73 sq M 59 mL/min/1.73 m² (low)
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1778-04-22 US Urinary bladder Volume post void 140 mL (high)
Reference Below 100 mL; 300 mL or more suggests chronic retention
http://loinc.org · 98856-8
S 1778-04-22 International Prostate Symptom Score [IPSS] 14 http://loinc.org · 80976-4
S 1778-04-22 Pain severity - 0-10 verbal numeric rating [Score] - Reported 5 http://loinc.org · 72514-3
S 1778-04-28 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 1778-04-28 Total score [Mini-Cog] 4 http://loinc.org · 72233-0
S 1778-05-06 Hemoglobin [Mass/volume] in Blood 10.8 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1778-05-06 Leukocytes [#/volume] in Blood by Automated count 6.9 10*3/uL
Reference 3.4-9.6 10*3/uL
http://loinc.org · 6690-2
S 1778-05-06 Platelets [#/volume] in Blood by Automated count 231 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1778-05-06 Potassium [Moles/volume] in Serum or Plasma 4.4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1778-05-06 Creatinine [Mass/volume] in Serum or Plasma 1.2 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1778-05-06 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1773)/1.73 sq M 60 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1778-05-06 US Urinary bladder Volume post void 120 mL (high)
Reference Below 100 mL; 300 mL or more suggests chronic retention
http://loinc.org · 98856-8
S 1778-05-06 International Prostate Symptom Score [IPSS] 15 http://loinc.org · 80976-4
S 1778-05-06 Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 http://loinc.org · 72514-3

Synthetic vital signs

DateMeasureResultLOINCGrade
1778-04-06Body height170 cm8302-2S
1778-04-06Body weight54.2 kg29463-7S
1778-04-06Body mass index (BMI) [Ratio]18.8 kg/m239156-5S
1778-04-06Systolic blood pressure138 mm[Hg]8480-6S
1778-04-06Diastolic blood pressure72 mm[Hg]8462-4S
1778-04-06Heart rate84 /min8867-4S
1778-04-06Respiratory rate16 /min9279-1S
1778-04-06Body temperature36.7 Cel8310-5S
1778-04-06Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
1778-04-13Body height170 cm8302-2S
1778-04-13Body weight54 kg29463-7S
1778-04-13Body mass index (BMI) [Ratio]18.7 kg/m239156-5S
1778-04-13Systolic blood pressure132 mm[Hg]8480-6S
1778-04-13Diastolic blood pressure70 mm[Hg]8462-4S
1778-04-13Heart rate80 /min8867-4S
1778-04-13Respiratory rate16 /min9279-1S
1778-04-13Body temperature36.6 Cel8310-5S
1778-04-13Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
1778-04-20Body height170 cm8302-2S
1778-04-20Body weight53.6 kg29463-7S
1778-04-20Body mass index (BMI) [Ratio]18.5 kg/m239156-5S
1778-04-20Systolic blood pressure118 mm[Hg]8480-6S
1778-04-20Diastolic blood pressure64 mm[Hg]8462-4S
1778-04-20Heart rate98 /min8867-4S
1778-04-20Respiratory rate18 /min9279-1S
1778-04-20Body temperature38.4 Cel8310-5S
1778-04-20Oxygen saturation in Arterial blood by Pulse oximetry95 %59408-5S
1778-04-22Body height170 cm8302-2S
1778-04-22Body weight53.4 kg29463-7S
1778-04-22Body mass index (BMI) [Ratio]18.5 kg/m239156-5S
1778-04-22Systolic blood pressure124 mm[Hg]8480-6S
1778-04-22Diastolic blood pressure68 mm[Hg]8462-4S
1778-04-22Heart rate82 /min8867-4S
1778-04-22Respiratory rate16 /min9279-1S
1778-04-22Body temperature36.9 Cel8310-5S
1778-04-22Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
1778-04-28Body height170 cm8302-2S
1778-04-28Body weight53.5 kg29463-7S
1778-04-28Body mass index (BMI) [Ratio]18.5 kg/m239156-5S
1778-04-28Systolic blood pressure126 mm[Hg]8480-6S
1778-04-28Diastolic blood pressure70 mm[Hg]8462-4S
1778-04-28Heart rate78 /min8867-4S
1778-04-28Respiratory rate16 /min9279-1S
1778-04-28Body temperature36.6 Cel8310-5S
1778-04-28Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
1778-05-06Body height170 cm8302-2S
1778-05-06Body weight53 kg29463-7S
1778-05-06Body mass index (BMI) [Ratio]18.3 kg/m239156-5S
1778-05-06Systolic blood pressure122 mm[Hg]8480-6S
1778-05-06Diastolic blood pressure68 mm[Hg]8462-4S
1778-05-06Heart rate80 /min8867-4S
1778-05-06Respiratory rate16 /min9279-1S
1778-05-06Body temperature36.7 Cel8310-5S
1778-05-06Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
Find the cause of the bleeding within three weeks1778-04-22completedCT urography in two days, cystoscopy in one week, resection in nine days; pathology reviewed at sixteen days
Relieve the retention and recover kidney function1778-04-22completedCreatinine 1.68 to 1.22 mg/dL; voiding after the trial without catheter with a residual of 140 mL
Treatment that controls bleeding and local symptoms while keeping him at home and writing1778-05-27activeWeekly radiotherapy under way; no clots or retention since the resection; writing most days
Pain at or below 3 of 10 without sedation, falls, or constipation1778-05-27activePain 2 of 10 on scheduled acetaminophen and about one half tablet of oxycodone a day; no sedation
A written plan for future care, with a named health care agent1778-04-28completedHealth care agent named and a portable medical order completed at the wellness visit

Interventions

InterventionStatusGuideline
Hematuria evaluation: urinalysis with microscopy, urine culture, urine cytology, blood count, kidney function, multiphasic CT urography with CT of the chest, and cystoscopycompletedGL-AUA-MH-2025, GL-CMID-2026
Urology consultation for gross hematuria with chronic retention: cystoscopy, resection if a tumor is found, the voiding trial, and the meaning of the PSAcompletedGL-AUA-MH-2025, GL-CMID-2026, GL-AUA-BPH-2023
Retention: indwelling catheter now, tamsulosin at bedtime, catheter care teaching, then a trial without catheter with a bladder scan; IPSS and post-void residual at each visitcompletedGL-AUA-BPH-2023, GL-IDSA-CAUTI-2009, GL-CMID-2026
Medication review: stop the diphenhydramine sleep aid and the over-the-counter sodium phosphate enemas; keep polyethylene glycol; cut coffee to two cups a day, none after noon; sleep advice without sedativescompletedGL-ASCO-GERI-2018, GL-BEERS-2023
Shared decision on PSA testing: drawn before the catheter to interpret an enlarged, firm prostate, with the understanding that a raised value at 83 would lead to biopsy only if it would change treatmentcompletedGL-AUA-BPH-2023, GL-USPSTF-PSA-2018
Transurethral resection of the bladder tumor with examination under anesthesia, for diagnosis and stagingcompletedGL-NCCN-BLADDER-2026, GL-AUA-MIBC-2024, GL-EAU-MIBC-2026, GL-CMID-2026
Geriatric assessment (G8 screen, function, falls, cognition, mood, nutrition, social support, and medicines) before choosing cancer treatmentcompletedGL-ASCO-GERI-2018, GL-BEERS-2023, GL-NCCN-BLADDER-2026
Shared decision on treatment of muscle-invasive squamous cell carcinoma: radical cystectomy, trimodality bladder preservation, palliative hypofractionated radiotherapy, or symptom care alone; he chose weekly radiotherapy, 36 Gy in six fractions, given by the radiation oncology teamcompletedGL-NCCN-BLADDER-2026, GL-AUA-MIBC-2024, GL-EAU-MIBC-2026, GL-CMID-2026, GL-HYBRID-2017
Pain plan: scheduled acetaminophen; oxycodone 2.5 mg only if needed, no more than three doses a day, 15 tablets at a time from one prescriber; naloxone nasal spray; senna; the state prescription monitoring program checked; no alcohol, sleep aids, or anyone else's opium-based remedies; doses kept in a locked box; review within two weekscompletedGL-CDC-OPIOID-2022, GL-BEERS-2023
Palliative care team joins his care alongside radiotherapy for symptom control, goals of care, and support at homecompletedGL-NCCN-BLADDER-2026, GL-ASCO-GERI-2018
Advance care planning: name a health care agent and complete a portable medical order reflecting his wishescompletedGL-PREV-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Pomeau RH. Voltaire. Encyclopaedia Britannica Encyclopaedia Britannica scholarly
SRC-0002 Pomeau RH. Voltaire: Achievements at Ferney. Encyclopaedia Britannica Encyclopaedia Britannica scholarly
SRC-0003 About Voltaire Voltaire Foundation, University of Oxford scholarly
SRC-0004 Voltaire. Letter to the baron de Breteuil, December 1723 (Correspondance, Garnier edition, letter 101) Wikisource primary
SRC-0005 Lachèvre F. Voltaire mourant: enquête faite en 1778 sur les circonstances de sa dernière maladie. Paris: Champion; 1908 Internet Archive (University of Toronto copy) primary
SRC-0006 Julien P. Les maladies et la mort de Voltaire: Jean Orieux, Voltaire ou la Royauté de l'esprit [review]. Revue d'histoire de la pharmacie 1970;58(204):60-61 Persée scholarly
SRC-0007 Russell A. Voltaire's thoughts on death. OUPblog, 29 May 2018 Oxford University Press other
SRC-0008 Charlier P, Neuzillet Y, Le Gendre R, Armengaud J. Paleoproteomic study of blood residues shows that Voltaire (1778) died of perforated bladder squamous cell cancer with peritoneal extension. BJU Int 2025;136(6):1002-1003. PMID 40977402 PubMed scholarly
SRC-0009 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the choice of squamous cell carcinoma, the decision against prostate biopsy, the choice of weekly palliative radiotherapy over cystectomy or trimodality therapy, the catheter and voiding-trial plan, the catheter-associated infection treatment, and the opioid plan.
provenance reviewnot_startedBritannica, the Voltaire Foundation, his 1723 letter on smallpox (Wikisource), Lachèvre's 1908 edition with Wagnière's account and the 1778 autopsy report (Internet Archive), a 1970 review of Orieux's biography (Persée), an OUP blog, and the 2025 BJU International record (title only) logged.
safe messaging reviewnot_startedNo behavioral-health diagnosis; the documented opium overdose is flagged sensitive and informs the opioid plan; death recorded without graphic detail; legends about his deathbed are not repeated.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.